Get started
Author

Emanuel Krebs

Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users
2017 · Linwei Wang, Jeong Eun Min, et al. · International Journal of Drug Policy · 128
Ending the HIV epidemic in the USA: an economic modelling study in six cities
2020 · Bohdan Nosyk, Xiao Zang, et al. · The Lancet HIV · 63
PDF
Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California
2017 · Emanuel Krebs, Benjamin Enns, et al. · Annals of Internal Medicine · 58
The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities
2019 · Emanuel Krebs, Xiao Zang, et al. · AIDS · 49
PDF
The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US Cities
2020 · Xiao Zang, Emanuel Krebs, et al. · Clinical Infectious Diseases · 48
PDF
The costs of crime during and after publicly funded treatment for opioid use disorders: a population‐level study for the state of California
2016 · Emanuel Krebs, Darren Urada, et al. · Addiction · 46
The effect of public health-oriented drug law reform on HIV incidence in people who inject drugs in Tijuana, Mexico: an epidemic modelling study
2018 · Annick Borquez, Leo Beletsky, et al. · The Lancet Public Health · 45
PDF
“Ending the Epidemic” Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus Epidemic
2020 · Bohdan Nosyk, Emanuel Krebs, et al. · Clinical Infectious Diseases · 44
PDF
Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis
2019 · Emanuel Krebs, Benjamin Enns, et al. · PLoS ONE · 42
PDF
Development and Calibration of a Dynamic HIV Transmission Model for 6 US Cities
2019 · Xiao Zang, Emanuel Krebs, et al. · Medical Decision Making · 41
PDF
Cost-Effectiveness Analysis in Implementation Science: a Research Agenda and Call for Wider Application
2021 · Emanuel Krebs, Bohdan Nosyk · Current HIV/AIDS Reports · 37
PDF
Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996–2013: a modelling study
2017 · Bohdan Nosyk, Xiao Zang, et al. · The Lancet HIV · 36
PDF
Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada
2020 · Micah Piske, Trevor Thomson, et al. · BMJ Open · 35
PDF
Ending the Epidemic in America Will Not Happen if the Status Quo Continues: Modeled Projections for Human Immunodeficiency Virus Incidence in 6 US Cities
2019 · Bohdan Nosyk, Xiao Zang, et al. · Clinical Infectious Diseases · 33
Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities
2021 · Amanda My Linh Quan, Cassandra Mah, et al. · The Lancet HIV · 30
Increased drug use and the timing of social assistance receipt among people who use illicit drugs
2016 · Emanuel Krebs, Linwei Wang, et al. · Social Science & Medicine · 25
PDF
Characterizing Long-Term Health Related Quality of Life Trajectories of Individuals With Opioid Use Disorder
2016 · Emanuel Krebs, Thomas Kerr, et al. · Journal of Substance Abuse Treatment · 25
Dynamics in the costs of criminality among opioid dependent individuals
2014 · Emanuel Krebs, Thomas Kerr, et al. · Drug and Alcohol Dependence · 25
Characterizing opioid agonist treatment discontinuation trends in British Columbia, Canada, 2012–2018
2021 · Emanuel Krebs, Fahmida Homayra, et al. · Drug and Alcohol Dependence · 22
Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study
2019 · Linwei Wang, Emanuel Krebs, et al. · The Lancet HIV · 21
Cost-effectiveness Analysis Along the Continuum of HIV Care: How Can We Optimize the Effect of HIV Treatment as Prevention Programs?
2014 · B. Nosyk, E. Krebs, et al. · Current HIV/AIDS Reports · 21
Toward Best Practices for Economic Evaluations of Tumor-Agnostic Therapies: A Review of Current Barriers and Solutions
2023 · Deirdre Weymann, Samantha Pollard, et al. · Value in Health · 20
PDF
The cascade of care for opioid use disorder among youth in British Columbia, 2018
2021 · Emanuel Krebs, Jeong E. Min, et al. · Journal of Substance Abuse Treatment · 20
Addressing immortal time bias in precision medicine: Practical guidance and methods development
2024 · Deirdre Weymann, Emanuel Krebs, et al. · Health Services Research · 18
PDF
The Cost-Effectiveness of Human Immunodeficiency Virus Testing and Treatment Engagement Initiatives in British Columbia, Canada: 2011–2013
2017 · Bohdan Nosyk, Jeong E Min, et al. · Clinical Infectious Diseases · 16
PDF
Works count: 89
Citation count: 1,173
H-index: 21
I10-index: 34
Year
Topic
Type